Greenwich Wealth Management LLC Has $1.54 Million Stock Holdings in CVS Health Co. (NYSE:CVS)

Greenwich Wealth Management LLC grew its position in CVS Health Co. (NYSE:CVS) by 3.9% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 24,557 shares of the pharmacy operator’s stock after purchasing an additional 922 shares during the period. Greenwich Wealth Management LLC’s holdings in CVS Health were worth $1,544,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in CVS. Norden Group LLC raised its holdings in CVS Health by 10.7% during the 1st quarter. Norden Group LLC now owns 6,830 shares of the pharmacy operator’s stock worth $545,000 after purchasing an additional 660 shares during the last quarter. Mission Wealth Management LP raised its holdings in CVS Health by 70.9% during the 1st quarter. Mission Wealth Management LP now owns 11,321 shares of the pharmacy operator’s stock worth $903,000 after purchasing an additional 4,696 shares during the last quarter. Prosperity Consulting Group LLC increased its stake in shares of CVS Health by 17.3% in the 1st quarter. Prosperity Consulting Group LLC now owns 4,331 shares of the pharmacy operator’s stock valued at $345,000 after acquiring an additional 638 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. raised its position in shares of CVS Health by 3.6% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 344,490 shares of the pharmacy operator’s stock valued at $26,047,000 after acquiring an additional 11,904 shares during the period. Finally, PDS Planning Inc raised its position in shares of CVS Health by 12.4% in the 1st quarter. PDS Planning Inc now owns 3,984 shares of the pharmacy operator’s stock valued at $318,000 after acquiring an additional 441 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Stock Down 1.2 %

Shares of NYSE:CVS traded down $0.65 during midday trading on Friday, hitting $55.81. The stock had a trading volume of 13,581,795 shares, compared to its average volume of 11,174,882. CVS Health Co. has a 12 month low of $52.77 and a 12 month high of $83.25. The company has a quick ratio of 0.66, a current ratio of 0.86 and a debt-to-equity ratio of 0.83. The business’s 50-day simple moving average is $59.66 and its 200-day simple moving average is $59.62. The company has a market cap of $70.21 billion, a P/E ratio of 9.93, a PEG ratio of 0.83 and a beta of 0.54.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, topping analysts’ consensus estimates of $1.73 by $0.10. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The firm had revenue of $91.23 billion during the quarter, compared to analysts’ expectations of $91.41 billion. During the same period in the previous year, the business posted $2.21 earnings per share. The company’s revenue for the quarter was up 2.6% compared to the same quarter last year. On average, sell-side analysts forecast that CVS Health Co. will post 6.41 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.77%. The ex-dividend date was Monday, October 21st. CVS Health’s dividend payout ratio is currently 47.33%.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on CVS shares. Wells Fargo & Company increased their price target on shares of CVS Health from $60.00 to $61.00 and gave the company an “equal weight” rating in a research report on Monday, August 12th. Royal Bank of Canada reiterated an “outperform” rating and issued a $68.00 price target on shares of CVS Health in a research report on Wednesday, September 4th. TD Cowen upgraded shares of CVS Health from a “hold” rating to a “buy” rating and increased their price target for the company from $59.00 to $85.00 in a research report on Friday, October 4th. Cantor Fitzgerald restated a “neutral” rating and set a $62.00 target price on shares of CVS Health in a report on Tuesday, October 1st. Finally, Deutsche Bank Aktiengesellschaft dropped their target price on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a report on Friday, August 9th. Nine investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, CVS Health has a consensus rating of “Moderate Buy” and an average price target of $74.58.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.